Stock Price
14.89
Daily Change
-0.11 -0.73%
Monthly
10.26%
Yearly
34.71%
Q1 Forecast
14.47

Amarin reported $3K in Interest Expense on Debt for its fiscal quarter ending in December of 2024.





Interest Expense On Debt Change Date
AbbVie USD 740M 40M Jun/2025
Alnylam Pharmaceuticals USD 44.4M 4.15M Sep/2025
Amarin USD 3K 5K Dec/2024
AstraZeneca USD 303M 38M Jun/2025
DBV Technologies USD 461K 323.71K Mar/2025
GlaxoSmithKline GBP 167M 17M Sep/2025
Halozyme Therapeutics USD 4.3M 98K Sep/2025
Ionis Pharmaceuticals USD 18M 1000K Sep/2025
Neurocrine Biosciences USD 1.1M 0 Mar/2024
Novartis USD 281M 8M Sep/2025